Psyence Biomedical Ltd. (PBM:NASDAQ) closed at $3.18 on November 11, 2026, up 4.95% on the day. The stock trades 97.3% below its 52-week high of $116.41 and 65.6% above its 52-week low of $1.92. Over the past year, it lost 97.1%. Psyence Biomedical Ltd. is part of the Health Care sector.
In 252 trading sessions since November 11, 2025, PBM closed higher on 111 days (44%). Its best day was April 16, 2026 (+103.82%) and its worst was January 20, 2026 (-84.00%). The stock moved 10% or more in a single session 30 times. It opened at least 5% above the previous day's high 4 times.
Psyence cultivates natural psilocybin mushrooms (Psilocybe Cubensis) at our federally licensed ISO22000 facility in Southern Africa. This product is produced for export to our partners across the world to beprocessed into a standardised encapsulated product.
Find more stocks like PBM with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.